Journal article
Attenuation of the Glucocorticoid Response during Ad5IL-12 Adenovirus Vector Treatment Enhances Natural Killer Cell–Mediated Killing of MHC Class I–Negative LNCaP Prostate Tumors
Abstract
Tumor cells can evolve to evade immune responses by down-modulating surface MHC class I expression and become refractory to T cell-directed immunotherapy. We employed a strategy to bypass this escape mechanism using a recombinant adenovirus vector expressing interleukin-12 (Ad5IL-12) to target natural killer (NK) cell-mediated killing of human prostate tumors in NOD.scid mice. Fluorescence-activated cell sorting analysis revealed that LNCaP …
Authors
Gabaglia CR; de Durana YD; Graham FL; Gauldie J; Sercarz EE; Braciak TA
Journal
Cancer Research, Vol. 67, No. 5, pp. 2290–2297
Publisher
American Association for Cancer Research (AACR)
Publication Date
March 1, 2007
DOI
10.1158/0008-5472.can-06-3399
ISSN
0008-5472
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdenoviridaeAnimalsAntineoplastic Agents, HormonalCombined Modality TherapyGenes, MHC Class IGenetic TherapyGenetic VectorsHumansHydrocortisoneImmunity, CellularImmunotherapyInterleukin-12Killer Cells, NaturalMaleMiceMice, Inbred NODMice, SCIDMitotaneProstatic NeoplasmsTumor Cells, CulturedXenograft Model Antitumor Assays